CD8A and myelodysplastic syndrome: Therefore, we purified CD8+ T cells from MDS patients and co‐cultured them with MDSCs, F38‐2E2 (TIM3 inhibitor) and 9M1‐3 (Gal‐9 inhibitor) respectively.